Kimio Yonesaka
- Oncology top 1%
- HER2/EGFR in Cancer Research 30
- Colorectal Cancer Treatments and Studies 18
- Cancer Immunotherapy and Biomarkers 9
- Peptidase Inhibition and Analysis 7
-
- Lung Cancer Treatments and Mutations 39
- Gastric Cancer Management and Outcomes 8
-
- Monoclonal and Polyclonal Antibodies Research 14
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
- Immunology top 10%
- Co-authors
- Kazuhiko NakagawaMasayuki TakedaHidetoshi HayashiKoji HarataniKaoru TanakaHiroyasu KanedaYasutaka ChibaRyoji Kato
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kimio Yonesaka
73 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 2.2k
- Pulmonary and Respiratory Medicine 1.2k
- Radiology, Nuclear Medicine and Imaging 489
- Cancer Research 265
- Immunology 304
Countries citing papers authored by Kimio Yonesaka
This map shows the geographic impact of Kimio Yonesaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimio Yonesaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimio Yonesaka more than expected).
Fields of papers citing papers by Kimio Yonesaka
This network shows the impact of papers produced by Kimio Yonesaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimio Yonesaka. The network helps show where Kimio Yonesaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kimio Yonesaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 66 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 59 | |
| 9 | 2019 | 10 | |
| 10 | 2017 | 41 | |
| 11 | 2017 | 19 | |
| 12 | 2017 | 182 | |
| 13 | 2015 | 12 | |
| 14 | 2013 | 86 | |
| 15 | 2012 | 2 | |
| 16 | 2010 | 8 | |
| 17 | 2010 | 181 | |
| 18 | 2008 | 96 | |
| 19 | 2006 | 14 | |
| 20 | Survivin inhibition by si-RNA induces apoptosis and increases sensitivity to adriamycin in human lung cancer cells with p53 mutation | 2004 | 12 |
About Kimio Yonesaka
Kimio Yonesaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 74 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (39 papers), HER2/EGFR in Cancer Research (30 papers), Colorectal Cancer Treatments and Studies (18 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Oncology (2.2k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Radiology, Nuclear Medicine and Imaging (489 citations). Kimio Yonesaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kazuhiko Nakagawa, Masayuki Takeda, Hidetoshi Hayashi, Koji Haratani, Kaoru Tanaka, Hiroyasu Kaneda, Yasutaka Chiba, Ryoji Kato, Keita Kudo and Yoshikazu Hasegawa.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.